相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Accumulation of carbapenem resistance mechanisms in VIM-2-producing Pseudomonas aeruginosa under selective pressure
G. Meletis et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2014)
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
Xavier Mulet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
IMP-33, a New IMP Variant Detected in Pseudomonas aeruginosa from Sicily
Lalitagauri M. Deshpande et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa
Damien Fournier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
Elena Riera et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Most Multidrug-Resistant Pseudomonas aeruginosa Isolates from Hospitals in Eastern France Belong to a Few Clonal Types
Pascal Cholley et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals
Maria Garcia-Castillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Population Structure of Pseudomonas aeruginosa from Five Mediterranean Countries: Evidence for Frequent Recombination and Epidemic Occurrence of CC235
Makaoui Maatallah et al.
PLOS ONE (2011)
Hydrolysis and Inhibition Profiles of beta-Lactamases from Molecular Classes A to D with Doripenem, Imipenem, and Meropenem
Anne Marie Queenan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa
Jose-Manuel Rodriguez-Martinez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Multidrug-Resistant Gram-Negative Infections What are the Treatment Options?
Helen Giamarellou et al.
DRUGS (2009)
Has the era of untreatable infections arrived?
David M. Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
First Countrywide Survey of Acquired Metallo-β-Lactamases in Gram-Negative Pathogens in Italy
Gian Maria Rossolini et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Evaluation of isolation methods and RNA integrity for bacterial RNA quantitation
Courtney E. Jahn et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2008)
First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase
Maria Virginia Villegas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2006)
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria
LJV Piddock
CLINICAL MICROBIOLOGY REVIEWS (2006)
Induction of the MexXY efflux pump in Pseudomonas aeruginosa is dependent on drug-ribosome interaction
K Jeannot et al.
JOURNAL OF BACTERIOLOGY (2005)
Italian metallo-beta-lactamases: A national problem? Report from the SENTRY Antimicrobial Surveillance Programme
MA Toleman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: Novel agents for combination therapy
O Lomovskaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Contribution of the MexX-MexY-OprM efflux system to intrinsic resistance in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)